Clinical Trials
26 trialsNCT04998864 2026-04-16
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
Completed
NCT07417774 2026-02-18
RESTORE LB
NuvOx LLC
Enrolling by invitation
NCT07366892 2026-01-26
IMED-GLOW400
Leica Microsystems (Schweiz) AG
Not yet recruiting
NCT06717295 2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT06038760 2025-07-30
PEAR-GLIO
Ourotech, Inc.
Terminated
NCT06924099 2025-04-11
TIGER France
NovoCure Ltd.
Recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT02905643 2024-02-22
Discerning Pseudoprogression vs True Tumor Growth in GBMs
Ascension Health
Terminated
NCT05958485 2023-07-24
A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research
Power Life Sciences Inc.
Not yet recruiting
NCT05728125 2023-06-12
Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
Power Life Sciences Inc.
Unknown
NCT03561207 2023-03-24
3D-PREDICT
KIYATEC
Unknown
NCT03793088 2023-02-03
XCELSIOR
xCures
Unknown
NCT04717739 2023-01-10
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study
NovoCure Ltd.
Unknown
NCT04219475 2022-04-19
PROPHETIC
OncoHost Ltd.
Suspended
NCT03258021 2021-01-28
TIGER
NovoCure Ltd.
Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT02300506 2018-11-05
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma
Eisai Inc.
Completed
NCT01618747 2018-02-28
An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse
Hoffmann-La Roche
Completed
NCT03152708 2017-09-21
CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
CANbridge Life Sciences Ltd.
Unknown
NCT02300532 2017-02-27
Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
Eisai Inc.
Completed
NCT00704808 2015-09-09
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
Merck Sharp & Dohme LLC
Completed
NCT00725010 2015-09-09
Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)
Merck Sharp & Dohme LLC
Completed
NCT01598597 2015-05-08
An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)
Genentech, Inc.
Completed
NCT00723827 2015-01-30
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
Merck Sharp & Dohme LLC
Completed
NCT00561873 2007-11-21
Nimotuzumab in Children With HGG
Oncoscience AG
Completed